Genotype-based prevention of psychosis onset and schizophrenia: a personalized approach in a target population

Personalized Medicine
Bahar TaneriJim van Os

Abstract

Schizophrenia imposes a significant burden on public health, affecting approximately 25 million individuals worldwide and generating an extensive healthcare burden. It is important to consider that the disease onset in schizophrenia stems from gene-environment interactions. Early interventions in order to prevent schizophrenia are of high clinical interest, and this is where personalized healthcare and medicine comes in. In this article, we bring a genotype-based personalized, preventive perspective to psychosis onset and schizophrenia. Our objective relies on the possibility of making use of a specific gene-environment interaction in the emergence of schizophrenia as a personalized preventive tool. In particular, we discuss screening of a specific AKT1 allelic variation and its interaction with cannabis use as a preventive approach in a target population with early symptoms of psychosis.

References

Oct 5, 2001·Nature Reviews. Molecular Cell Biology·M P Scheid, J R Woodgett
Nov 17, 2001·Trends in Biotechnology·G S Ginsburg, J J McCarthy
Jul 23, 2002·Current Opinion in Chemical Biology·Joanne M Meyer, Geoffrey S Ginsburg
Aug 16, 2002·American Journal of Epidemiology·J van OsH Verdoux
Oct 25, 2003·Science·Kathleen Ries Merikangas, Neil Risch
Jan 28, 2004·Nature Genetics·Effat S EmamianJoseph A Gogos
Jun 23, 2004·Lancet·Kim T Mueser, Susan R McGurk
Nov 4, 2004·Biological Psychiatry·Masashi IkedaNorio Ozaki
Feb 22, 2005·Current Molecular Medicine·Penelope K Manasco
Mar 23, 2005·Biological Psychiatry·Deepak Cyril D'SouzaJohn Harrison Krystal
Sep 29, 2005·The Journal of Clinical Psychiatry·Eric Q WuJyoti Aggarwal
Apr 4, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Sepideh N BajestanMitsuhiro Osame
Jan 31, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Susan MooreChristopher Flowers
May 9, 2007·Journal of Neurochemistry·Andrés OzaitaRafael Maldonado
Oct 11, 2007·Nature Reviews. Neuroscience·Robin M MurrayMarta Di Forti
Mar 28, 2008·PLoS Biology·Timothy CaulfieldMichael Timmons
May 3, 2008·Acta Psychiatrica Scandinavica·M KoningsJ Van Os
Aug 30, 2008·Schizophrenia Bulletin·Cécile HenquetRobin M Murray
Dec 11, 2008·JAMA : the Journal of the American Medical Association·Amy L McGuire, Wylie Burke
Mar 5, 2009·European Journal of Human Genetics : EJHG·David Gurwitz, Yael Bregman-Eschet
Aug 25, 2009·Lancet·Jim van Os, Shitij Kapur
Nov 27, 2009·Genome Medicine·Pascal Borry
Jun 17, 2010·The New England Journal of Medicine·Margaret A Hamburg, Francis S Collins
Jun 30, 2010·PLoS Genetics·Greg Gibson, Gregory P Copenhaver
Oct 6, 2010·Archives of General Psychiatry·UNKNOWN Genetic Risk and Outcome in Psychosis (GROUP) Investigators
Nov 3, 2010·Archives of General Psychiatry·Ruud van Winkel, UNKNOWN Genetic Risk and Outcome of Psychosis (GROUP) Investigators
Nov 12, 2010·Nature·Jim van OsBart P F Rutten
May 3, 2011·Neuroscience and Biobehavioral Reviews·Paola CasadioMarta Di Forti
Jul 22, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ruud van WinkelUNKNOWN Genetic Risk and Outcome of Psychosis (GROUP) Investigators
Sep 8, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H U WittchenH-C Steinhausen
Sep 20, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Anders GustavssonUNKNOWN CDBE2010Study Group
Mar 22, 2012·Frontiers in Molecular Neuroscience·Effat S Emamian
Jun 22, 2012·Current Pharmaceutical Design·Jeroen DecosterRuud van Winkel
Jun 22, 2012·Current Pharmaceutical Design·Jose Maria Pelayo-TeránBenedicto Crespo-Facorro
Jan 22, 2013·BMJ : British Medical Journal·Megan R StaffordTim Kendall
Feb 20, 2013·The Journal of Clinical Psychiatry·Jussi A Niemi-PynttäriSami P Pirkola

❮ Previous
Next ❯

Citations

Aug 12, 2017·The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body·Steven Daws

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Psychiatry
Marie-Odile KrebsA Dervaux
The American Journal of Psychiatry
Darryl Wade
© 2022 Meta ULC. All rights reserved